| Particulars |
|
|
|
| Company Name
| Concord Biotech Ltd
| Year End
| 202403
|
| Full Year |
| Equity (₹ Cr.) |
10.46 |
B.V. (₹) |
152.00 |
| Sales(₹ Cr.) |
1,016.94 |
NP (₹ Cr.) |
294.25 |
| NP Var% |
25.00 |
Div% |
875.00 |
| CPS(₹) |
33.20 |
EPS (₹) |
28.10 |
| Traded Value(₹ Lakhs) |
193.89 |
52 Week High |
2,658.00 |
| 52 Week Low |
1,327.00 |
Price BSE |
2,329.00 |
| Price NSE |
2,327.00 |
Market Capital (₹ Cr.) |
24,368.25 |
| P/C Ratio |
70.00 |
P/E Ratio |
82.80 |
| Price Vs.BV |
15.32 |
|
| Latest Quarter |
| Year End |
202409 |
Sales (₹ Cr.) |
310.18 |
| NP(₹ Cr.) |
98.70 |
NP Var % |
17.00 |
| Trailing Twelve Months |
| Year End |
202409 |
Sales |
1,085.75 |
| OPM |
42.20 |
NP |
328.71 |
| NP Var% |
7.58 |
EPS |
31.42 |
| PE |
74.13 |
|
|